Charity attacks Gilead over hepatitis C drug restrictions

The medical charity Medecins Sans Frontieres has accused U.S. drugmaker Gilead Sciences Inc of restricting access to its breakthrough hepatitis C drug Sovaldi in developing countries as it tries to protect profit margin in wealthier nations.

http://www.reuters.com/article/2015/03/18/gilead-sciences-msf-idUSL2N0WK2Q920150318

YOU ARE BEING REDIRECTED TO THE ARTICLE
. . .
× CLOSE

PROCESSING